Has Jorge Garces, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,136 in general payments to Jorge Garces, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jorge Garces, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jorge Garces, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jorge Garces, MD

Nephrology · New Orleans, LANPI 1801854609

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,820 of the $2,136 with a category attached, or 85.2%. It is spread thinly across 15 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $629 and has fallen 76.7% since, to $147 in 2025. That places this record below the midpoint for nephrology clinicians in LA, where the typical reported total is $1,900.

$2,136in general payments, 2019–2025

Across 24 payments — averaging $89.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Veloxis Pharmaceuticals, Inc.$348
AstraZeneca$344
Vifor Pharma, Inc.$314
Calliditas Therapeutics US Inc.$228
Bayer$225
Sanofi-aventis U.S. LLC$112
plus $565 from 9 others

What the payments were for

Speaking & faculty fees$2009%
Food & beverage$1,82085%
Education$1165%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Veloxis Pharmaceuticals, Inc.	4	$348
AstraZeneca(2 entities)	3	$344
Vifor Pharma, Inc.	2	$314
Calliditas Therapeutics US Inc.	2	$228
Bayer	2	$225
Sanofi-aventis U.S. LLC	2	$112
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$99
Sanofi	1	$87
Aurinia Pharma U.S., Inc.	1	$87
Amgen	1	$78
Otsuka America Pharmaceutical, Inc.	1	$78
Rockwell Medical, Inc.	1	$61
Vertex	1	$30
Travere Therapeutics, Inc.	1	$25
Nxstage Medical, Inc.	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,136 in reported general payments places this provider in the 50th percentile of 206 nephrology providers in Louisiana.

See all nephrology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$19,668

Medicare patients

Services billed

160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
NulojixBelatacept	13	$25,192
VeltassaPatiromer Calcium Sorbitex	28	$22,660
EliquisApixaban	14	$10,931
Cinacalcet Hcl	72	$10,804
Valganciclovir Hcl	68	$10,159
Atovaquone	16	$7,723
Tacrolimus	57	$5,412
Nifedipine ErNifedipine	118	$2,120
Mycophenolic AcidMycophenolate Sodium	21	$1,744
Humalog Kwikpen U-100Insulin Lispro	14	$1,731
Novolog FlexpenInsulin Aspart	13	$1,668
Mycophenolate Mofetil	20	$1,649
Ketoconazole	69	$1,219
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic	11	$910
Carvedilol	85	$601

Paid to pharmacies, not to this prescriber.

Other nephrology in New Orleans

Juan Carlos VelezNew Orleans$282K
Michael TouchyNew Orleans$56K
Juan MedauraNew Orleans$14K
Farshid YazdiNew Orleans$14K
Mihran NaljayanNew Orleans$10K
Rhea BhargavaNew Orleans$9K
April FoxNew Orleans$8K
Myra KleinpeterNew Orleans$7K
Joshua LowentrittNew Orleans$7K
Angela ReginelliNew Orleans$6K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →